VOLITIONRX LIMITED financials

VNRX CIK 0000093314

Source: EDGAR filings · Built 2026-06-19T01:43:45Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -19.77M -26.17M -19.19M -16.89M -21.89M -18.50M
EBITDA -20.75M -25.91M -34.84M -30.84M -27.39M -20.53M
Working Capital -10.17M -3.73M 12.91M -5.21M 15.46M 14.10M
Net Debt 6.49M 2.56M -14.87M -5.89M -16.56M -15.10M
Operating Margin -1258.47% -2190.90% -4641.76% -10372.36% -31468.96% -158176.25%
Net Margin -1352.16% -2186.27% -4601.70% -9986.71% -29976.99% -151859.55%
Return on Equity (ROE) 68.20% 108.27% 457.27% 1188.29% -152.29% -125.20%
Return on Assets (ROA) -338.45% -286.91% -127.64% -167.25% -98.18% -78.01%
Current Ratio 0.17× 0.52× 2.44× 0.70× 3.37× 3.26×
Debt-to-Equity -0.22× -0.23× -0.75× -1.93× 0.23× 0.27×
Cash Conversion Ratio 0.84× 0.96× 0.51× 0.50× 0.77× 0.81×
Accruals Ratio -0.53× -0.11× -0.63× -0.84× -0.22× -0.15×
SBC % of Revenue 100.71% 102.84% 295.31% 1016.56% 2721.55% 10358.76%
CapEx Coverage -219.78× -93.31× -15.98× -9.46× -20.21× -8.08×
Free Cash Flow Per Share $-0.19 $-0.30 $-0.27 $-0.42 $-0.41

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 1.73M 1.23M 775.30K 306.39K 90.03K 13.43K
Research and Development Expense 10.08M 14.41M 19.55M 15.33M 13.02M 14.53M
Operating Expenses 23.47M 28.26M 36.76M 32.09M 28.42M 21.26M
Operating Income (Loss) -21.74M -27.02M -35.99M -31.78M -28.33M -21.25M
Net Income (Loss) Attributable to Parent -23.36M -26.97M -35.68M -30.60M -26.99M -20.40M
Earnings Per Share, Diluted $-0.31 $-0.50
Weighted Average Number of Shares Outstanding, Diluted 106.83M 86.53M 71.23M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.12M 3.26M 20.73M 10.87M 20.58M 19.44M
Assets, Current 2.06M 4.06M 21.85M 12.17M 21.98M 20.33M
Assets 6.90M 9.40M 27.95M 18.30M 27.49M 26.15M
Long-term Debt 6.71M 4.81M 4.83M 3.85M 3.07M 3.45M
Liabilities, Current 12.23M 7.79M 8.94M 17.39M 6.52M 6.24M
Long-term Debt, Excluding Current Maturities 5.82M 3.95M 3.62M 2.78M 2.27M 2.61M
Liabilities 42.49M 35.51M 36.66M 21.42M 9.77M 9.86M
Stockholders' Equity Attributable to Parent -34.25M -24.91M -7.80M -2.57M 17.72M 16.29M
Common Stock, Shares, Outstanding 6.29M 96.10M 81.90M 57.87M 53.77M 48.61M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -19.68M -25.89M -18.06M -15.28M -20.85M -16.46M
Payments to Acquire Property, Plant, and Equipment 89.56K 277.50K 1.08M 1.57M 973.56K 1.94M
Net Cash Provided by (Used in) Investing Activities -89.56K -573.85K -1.08M -1.57M -973.56K -1.65M
Payments for Repurchase of Common Stock 0 31.77K 0
Net Cash Provided by (Used in) Financing Activities 17.09M 8.66M 28.98M 6.94M 22.86M 20.62M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VNRX CIK 0000093314), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

UHS

UNIVERSAL HEALTH SERVICES, INC.

CYH

COMMUNITY HEALTH SYSTEMS, INC.

MNR

Mach Natural Resources LP